About Aspen Neuroscience
Aspen Neuroscience develops and delivers autologous cell replacement therapies for patients with high unmet medical need, beginning with Parkinson’s disease. It uses a person’s own cells to help restore function. Aspen Neuroscience aims to make personalized cell therapy commercially viable at scale.
Company Details
Corporate & Operational Profile
Web & Domain Identity
Social & Network Presence
Company Milestones & Timeline
- Capital Raise
Raised $115,000,000 · Series-B+
fundraisingfox.com
- Capital Raise
Raised $147,500,000 · Series-B+
- Capital Raise
Raised $70,000,000 · Series-A
- Capital Raise
Raised $6,500,000 · Seed
- Milestone
X account created (@AspenNeuro)
376 followers
- Milestone
Website domain registered
aspenneuroscience.com
- Milestone
Company founded
La Jolla, United States
Investors & Backers
Funding History
Founders & Leadership
Ana Sousa
Chief Regulatory Officer
Andrés Bratt-Leal
Co-Founder
Damien McDevitt
President and Chief Executive Officer
Jeanne Loring
Founder
Kameel Farag
CFO
Kim Raineri
Chief Technology Officer
Lisa Johnson-Pratt
Senior Vice President, Therapeutic Program Lead
Xiaokui Zhang
Chief Scientific Officer
Press Coverage & Sources
fundraisingfox.com/companies/aspen-neuroscience
sdbj.com/news/2022/may/18/aspen-neuroscience-raises-1475m-series-b/
blog.socaltech.com/aspen_neuroscience_gets_7_m/s-0079700.html
finsmes.com/2019/12/aspen-neuroscience-raises-6-5m-in-seed-funding.html
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Hexagon Bio
hexagonbio.com
RefloDx
reflodx.com
HeyVoli
heyvoli.com
CureBay
curebay.com
4Tissue
4tissue.com